CMMB Q4 2017 Earnings — Chemomab Therapeutics Ltd. Revenue & Financial Results | Market Cap Arena

CMMBChemomab Therapeutics Ltd.

$12M

Q4 2017 Earnings

Revenue

Gross Profit

-$14,877

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-162.81

QoQ Revenue Growth

NaN%

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$14,877	-$15,099	+1.5%
Operating Income	-$2M	-$1M	-29.5%
Net Income	-$2M	-$1M	-40.7%